Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer.
Saved in:
| Title: | Addition of angiogenesis inhibitors to CDK4/6 inhibitors and fulvestrant in hormone receptor-positive, HER2-negative advanced breast cancer. |
|---|---|
| Authors: | Zhang M; Department of Breast Disease, Henan Breast Cancer Center/The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan 450003, China., Niu L, Lyu H, Liu Z, Zeng H, Lu Z, Chen X, Qiao J, Yuan P, Zhao S, Sun H, Wang J, Feng Y, Yan M |
| Source: | Chinese medical journal [Chin Med J (Engl)] 2026 Jul 07. Date of Electronic Publication: 2026 Jul 07. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Chinese Medical Association ; produced by Wolters Kluwer Country of Publication: China NLM ID: 7513795 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2542-5641 (Electronic) Linking ISSN: 03666999 NLM ISO Abbreviation: Chin Med J (Engl) Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2542-5641 |
|---|---|
| DOI: | 10.1097/CM9.0000000000004191 |
